Literature DB >> 10671335

An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel.

R Dagan1, S Gradstein, I Belmaker, N Porat, Y Siton, G Weber, J Janco, P Yagupsky.   

Abstract

An outbreak of Streptococcus pneumoniae serotype 1 occurred in a closed community that was characterized by poverty and crowding. Vaccine was administered to individuals aged >2 years; no new cases occurred among vaccine recipients. Six weeks after vaccination, carriage of serotype 1, but not of other serotypes, decreased 8.8-fold. This suggests that the reduction in serotype 1 carriage reflects the natural course of the outbreak rather than a vaccine effect. Polysaccharide vaccine may be helpful in terminating pneumococcal outbreaks but may not affect pneumococcal carriage.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10671335     DOI： 10.1086/313645

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  33 in total

1.  Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel.

Authors:  N Porat; R Trefler; R Dagan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007.

Authors:  S Le Hello; M Watson; M Levy; S Marcon; M Brown; J F Yvon; I Missotte; B Garin
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

3.  Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

Authors:  Angela B Brueggemann; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

4.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

5.  Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

Authors:  N Grall; O Hurmic; M Al Nakib; M Longo; C Poyart; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

6.  Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska.

Authors:  Tammy Zulz; Jay D Wenger; Karen Rudolph; D Ashley Robinson; Alexey V Rakov; Dana Bruden; Rosalyn J Singleton; Michael G Bruce; Thomas W Hennessy
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

7.  Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France area.

Authors:  J-W Decousser; P Ovetchkine; A Collignon; C Chaplain; E Estrangin; A Fremaux; P Reinert; P Foucaud; J-C Ghnassia; R Cohen; J Gaudelus; P-Y Allouch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-02       Impact factor: 3.267

8.  Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel.

Authors:  David Greenberg; Ron Dagan; Marie Muallem; Nurith Porat
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.

Authors:  B Quintero; M Araque; C van der Gaast-de Jongh; F Escalona; M Correa; S Morillo-Puente; S Vielma; P W M Hermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-30       Impact factor: 3.267

10.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.